p16INK4a inactivation is not frequent in uncultured sporadic primary cutaneous melanoma
暂无分享,去创建一个
M. Takata | A. Fujimoto | K. Takehara | N. Hatta | R. Morita
[1] M. Takata,et al. Comparison of genetic profiles between primary melanomas and their metastases reveals genetic alterations and clonal evolution during progression. , 1998, The Journal of investigative dermatology.
[2] G. Walker,et al. Virtually 100% of melanoma cell lines harbor alterations at the DNA level within CDKN2A, CDKN2B, or one of their downstream targets , 1998, Genes, chromosomes & cancer.
[3] J. Herman,et al. Hypermethylation can selectively silence individual p16ink4A alleles in neoplasia. , 1998, Cancer research.
[4] V. Gouyer,et al. Mechanisms of p16INK4A inactivation in non small-cell lung cancers , 1998, Oncogene.
[5] W. Farrell,et al. Chromosome 9p deletions in invasive and noninvasive nonfunctional pituitary adenomas: the deleted region involves markers outside of the MTS1 and MTS2 genes. , 1997, Cancer research.
[6] M. Broggini,et al. Absence of deletions but frequent loss of expression of p16INK4 in human ovarian tumours. , 1997, British Journal of Cancer.
[7] G. Chenevix-Trench,et al. Rare mutations and no hypermethylation at the CDKN2A locus in epithelial ovarian tumours , 1997, International journal of cancer.
[8] B. Leggett,et al. Frequency of mutation and deletion of the tumor suppressor gene CDKN2A (MTS1/p16) in hepatocellular carcinoma from an Australian population , 1997, Hepatology.
[9] William D. Foulkes,et al. The CDKN2A (p16) Gene and Human Cancer , 1997, Molecular medicine.
[10] K. Ichimura,et al. Infrequent methylation of CDKN2A(MTS1/p16) and rare mutation of both CDKN2A and CDKN2B(MTS2/p15) in primary astrocytic tumours. , 1997, British journal of cancer.
[11] J. Herman,et al. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[12] E. Healy,et al. Infrequent mutation of p16INK4 in sporadic melanoma. , 1996, The Journal of investigative dermatology.
[13] C. Shields,et al. Deletion mapping of chromosome region 9p21‐p22 surrounding the CDKN2 locus in melanoma , 1996, International journal of cancer.
[14] E. Hovig,et al. CDKN2A (p16INK4A) somatic and germline mutations , 1996, Human mutation.
[15] R. Beart,et al. Methylation of the 5' CpG island of the p16/CDKN2 tumor suppressor gene in normal and transformed human tissues correlates with gene silencing. , 1995, Cancer research.
[16] Kathleen R. Cho,et al. Frequency of homozygous deletion at p16/CDKN2 in primary human tumours , 1995, Nature Genetics.
[17] J. Herman,et al. 5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers , 1995, Nature Medicine.
[18] E. Healy,et al. Loss of heterozygosity in sporadic primary cutaneous melanoma , 1995, Genes, chromosomes & cancer.
[19] W. Clark,et al. Germline p16 mutations in familial melanoma , 1994, Nature Genetics.
[20] M. Skolnick,et al. Analysis of the p16 gene (CDKN2) as a candidate for the chromosome 9p melanoma susceptibility locus , 1994, Nature Genetics.
[21] M H Skolnick,et al. Localization of a putative tumor suppressor gene by using homozygous deletions in melanomas. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[22] N. Hayward,et al. Microsatellite instability in melanoma. , 1994, Melanoma research.
[23] N. Hayward,et al. Simple tandem repeat allelic deletions confirm the preferential loss of distal chromosome 6q in melanoma , 1994, International journal of cancer.
[24] Cécile Fizames,et al. The 1993–94 Généthon human genetic linkage map , 1994, Nature Genetics.
[25] D. Carson,et al. Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers , 1994, Nature.
[26] M. Skolnick,et al. A cell cycle regulator potentially involved in genesis of many tumor types. , 1994, Science.
[27] J. Kirkwood,et al. Homozygous deletions within human chromosome band 9p21 in melanoma. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[28] S. Ferrone,et al. Differential expression of melanoma associated antigens in acral lentiginous melanoma and in nodular melanoma lesions. , 1991, Cancer research.
[29] D. Housman,et al. Genetics of melanoma. , 1990, Cancer surveys.
[30] W. Coleman,et al. Acral Lentiginous Melanoma: A Clinicopathologic Entity , 1982, Annals of surgery.